_factor-xa-inhibitors-preview-1.jpg "Factor Xa Inhibitors from factor 10 inhibitors Video Screenshot Preview 1")
Gallery_factor-xa-inhibitors-preview-3.jpg "Factor Xa Inhibitors from factor 10 inhibitors Video Screenshot Preview 3")
Gallery_factor-xa-inhibitors-preview-hqdefault.jpg "Factor Xa Inhibitors from factor 10 inhibitors Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 5 minutes 44 seconds
👁 View: 232 times
Play Audio:👁 View: 232 times
Description:
Johnson Francis, MBBS, MD, DM
Johnson Francis, MBBS, MD, DM
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_rivaroxaban-powder-366789-02-8-hplc98-124-aasraw-rampd-reagents.webp "Rivaroxaban powder (366789-02-8) hplc≥98% | AASraw R&D Reagentsnnhttp://www.aasraw.com/products/rivaroxaban-powder/nnRivaroxaban powder basic Characters:nnName:tRivaroxaban powdernCAS:t366789-02-8nMolecular Formula:tC19H18ClN3O5SnMolecular Weight:t435.88nMelt Point:t228-229°CnStorage Temp:t-20°C FreezernColor:tWhite to yellowish powdernnII. Rivaroxaban Powder usage:nn1.Name:nRivaroxaba, Xarelto.nn2.Rivaroxaban Powder usage:nRivaroxaban powder is an anticoagulant and the first orally ac")
_factor-xa-inhibitors-rivaroxaban-mnemonic-for-nursing-pharmacology-nclex.webp "Pixorize")
⏲ 5 minutes 4 seconds 👁 7.2K
_factor-xa-inhibitors.webp "Johnson Francis, MBBS, MD, DM")
_webinar-coping-with-skin-rash.webp "Presented 10/19/2011nnCertain drugs that treat colorectal cancer, like Erbitux or Vectibix, can cause painful rashes, dry skin and nail problems. These side effects are unpleasant, can hurt and are often embarrassing. nnThe good news is that there are things patients can do to reduce the severity of these side effects. nnJoin Fight Colorectal Cancer and oncology nurse Pamela nViale for a free patient webinar that discusses the prevention and management of skin toxicities related to EGFR inhibito")
_factor-xi-inhibitors-what-should-clinicians-know.webp "CRITICAL CODE")
_factor-xa-inhibitors-clinical-trial-results-in-atherosclerosis.webp "HCPLive")
_factor-xa-inhibitors-124-direct-thrombin-inhibitors-124-anticoagulant-drugs-124-doacs-124.webp "BMH learning")
⏲ 1 minute 59 seconds 👁 547
_direct-acting-oral-anticoagulants-doacs-124-moa-indications-adverse-reactions-contraindications.webp "Ninja Nerd")
⏲ 27 minutes 51 seconds 👁 40K
_rivaroxaban-powder-366789-02-8-hplc98-124-aasraw-rampd-reagents.jpg)
_factor-xa-inhibitors-rivaroxaban-mnemonic-for-nursing-pharmacology-nclex.jpg)
_factor-xa-inhibitors.jpg)
_webinar-coping-with-skin-rash.jpg)
_factor-xi-inhibitors-what-should-clinicians-know.jpg)
_factor-xa-inhibitors-clinical-trial-results-in-atherosclerosis.jpg)
_factor-xa-inhibitors-124-direct-thrombin-inhibitors-124-anticoagulant-drugs-124-doacs-124.jpg)
_direct-acting-oral-anticoagulants-doacs-124-moa-indications-adverse-reactions-contraindications.jpg)
![[+]](/images/menu.gif){kind=small}